Attached files
| file | filename |
|---|---|
| EX-21 - EXHIBIT 21 - Sucampo Pharmaceuticals, Inc. | exh_21.htm |
| EX-23.2 - EXHIBIT 23.2 - Sucampo Pharmaceuticals, Inc. | exh_232.htm |
| EX-32.2 - EXHIBIT 32.2 - Sucampo Pharmaceuticals, Inc. | exh_322.htm |
| EX-31.1 - EXHIBIT 31.1 - Sucampo Pharmaceuticals, Inc. | exh_311.htm |
| EX-32.1 - EXHIBIT 32.1 - Sucampo Pharmaceuticals, Inc. | exh_321.htm |
| EX-31.2 - EXHIBIT 31.2 - Sucampo Pharmaceuticals, Inc. | exh_312.htm |
| EX-10.41 - EXHIBIT 10.41 - Sucampo Pharmaceuticals, Inc. | exh_1041.htm |
| EX-10.35 - EXHIBIT 10.35 - Sucampo Pharmaceuticals, Inc. | exh_1035.htm |
| EX-10.38 - EXHIBIT 10.38 - Sucampo Pharmaceuticals, Inc. | exh_1038.htm |
| EX-10.40 - EXHIBIT 10.40 - Sucampo Pharmaceuticals, Inc. | exh_1040.htm |
| 10-K - FORM 10-K - Sucampo Pharmaceuticals, Inc. | f10k_030816p.htm |
| EX-10.36 - EXHIBIT 10.36 - Sucampo Pharmaceuticals, Inc. | exh_1036.htm |
| EX-10.39 - EXHIBIT 10.39 - Sucampo Pharmaceuticals, Inc. | exh_1039.htm |
| EX-10.37 - EXHIBIT 10.37 - Sucampo Pharmaceuticals, Inc. | exh_1037.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
| (1) | Registration Statement (Form S-8 No. 333-147420) pertaining to the 2006 Employee Stock Purchase Plan, the 2006 Stock Incentive Plan, as amended and restated, and the Amended and Restated 2001 Stock Incentive Plan of Sucampo Pharmaceuticals, Inc., and |
| (2) | Registration Statement (Form S-3 No. 333-201566) of Sucampo Pharmaceuticals, Inc. |
of our reports dated March 9, 2016, with respect to the consolidated financial statements and schedule of Sucampo Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Sucampo Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Sucampo Pharmaceuticals, Inc. for the year ended December 31, 2015.
/s/ Ernst & Young LLP
McLean, Virginia
March 9, 2016